These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12680862)

  • 21. Is faster safer? Cluster versus short conventional subcutaneous allergen immunotherapy.
    Quiralte J; Justicia JL; Cardona V; Dávila I; Moreno E; Ruiz B; García MA
    Immunotherapy; 2013 Dec; 5(12):1295-303. PubMed ID: 24283840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of sublingual grass pollen immunotherapy after anaphylaxis.
    Nichani JR; de Carpentier J
    J Laryngol Otol; 2009 Jun; 123(6):683-4. PubMed ID: 18501039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective safety study of immunotherapy administered in a cluster schedule.
    Serrano P; Algorta J; Martínez A; González-Quevedo T; Velázquez E; Díaz M
    J Investig Allergol Clin Immunol; 2004; 14(4):312-9. PubMed ID: 15736717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Safety of immunotherapy and skin tests with allergens in children younger than five years].
    Rodríguez Pérez N; Ambriz Moreno Mde J
    Rev Alerg Mex; 2006; 53(2):47-51. PubMed ID: 16884027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunotherapy with a depigmented, polymerized vaccine of Olea europaea pollen allergens. Significantly reduces specific bronchial and skin test reactivity in sensitized patients after one year of treatment.
    Guerra F; Daza JC; Almeda E
    J Investig Allergol Clin Immunol; 2003; 13(2):108-17. PubMed ID: 12968395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of immunotherapy in patients with rhinitis, asthma or atopic dermatitis using an ultra-rush buildup. A retrospective study.
    Cardona R; Lopez E; Beltrán J; Sánchez J
    Allergol Immunopathol (Madr); 2014; 42(2):90-5. PubMed ID: 23265265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Side effects during immunotherapy with purified grass pollen extracts.
    Osterballe O
    Allergy; 1982 Nov; 37(8):553-62. PubMed ID: 7181051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local reactions from subcutaneous allergen immunotherapy.
    Coop CA
    Immunotherapy; 2013 Dec; 5(12):1339-45. PubMed ID: 24283844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): A paediatric assessment.
    Rodríguez Del Río P; Vidal C; Just J; Tabar AI; Sanchez-Machin I; Eberle P; Borja J; Bubel P; Pfaar O; Demoly P; Calderón MA
    Pediatr Allergy Immunol; 2017 Feb; 28(1):60-70. PubMed ID: 27637414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allergen-specific immunotherapy in birch- and grass-pollen-allergic rhinitis. II. Side-effects.
    Winther L; Malling HJ; Mosbech H
    Allergy; 2000 Sep; 55(9):827-35. PubMed ID: 11003446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic reactions due to allergen immunotherapy.
    Karaayvaz M; Erel F; Caliskaner Z; Ozangüç N
    J Investig Allergol Clin Immunol; 1999; 9(1):39-44. PubMed ID: 10212856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 10-year experience of a novel and safe modified environmental rush immunotherapy protocol.
    Fajt ML; Rosenberg SL; Yecies E; Traister RS; Petrov AA
    Allergy Asthma Proc; 2017 Jul; 38(4):309-316. PubMed ID: 28668111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific subcutaneous immunotherapy with recombinant grass pollen allergens: first randomized dose-ranging safety study.
    Klimek L; Schendzielorz P; Pinol R; Pfaar O
    Clin Exp Allergy; 2012 Jun; 42(6):936-45. PubMed ID: 22909165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased frequency of large local reactions among systemic reactors during subcutaneous allergen immunotherapy.
    Roy SR; Sigmon JR; Olivier J; Moffitt JE; Brown DA; Marshall GD
    Ann Allergy Asthma Immunol; 2007 Jul; 99(1):82-6. PubMed ID: 17650835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local and systemic reactions occurring during immunotherapy: an epidemiological evaluation and a prospective safety-monitoring study.
    Ventura MT; Giuliano G; Buquicchio R; Accettura F; Carbonara M
    Immunopharmacol Immunotoxicol; 2008; 30(1):153-61. PubMed ID: 18306111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety considerations in assessing the role of immunotherapy in allergic disorders.
    Bousquet J; Michel FB
    Drug Saf; 1994 Jan; 10(1):5-17. PubMed ID: 8136087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The LOCAL Study: Local reactions do not predict local reactions in allergen immunotherapy.
    Calabria CW; Coop CA; Tankersley MS
    J Allergy Clin Immunol; 2009 Oct; 124(4):739-44. PubMed ID: 19767075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of systemic allergic reactions to allergen immunotherapy in a pediatric allergy clinic in Turkey.
    Bahceci Erdem S; Nacaroglu HT; Karaman S; Unsal Karkıner CS; Gunay I; Dogan D; Asilsoy S; Altınoz S; Can D
    Int J Pediatr Otorhinolaryngol; 2016 May; 84():55-60. PubMed ID: 27063754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insect Venom Immunotherapy: Analysis of the Safety and Tolerance of 3 Buildup Protocols Frequently Used in Spain.
    Gutiérrez Fernández D; Moreno-Ancillo A; Fernández Meléndez S; Domínguez-Noche C; Gálvez Ruiz P; Alfaya Arias T; Carballada González F; Alonso Llamazares A; Marques Amat L; Vega Castro A; Antolín Amérigo D; Cruz Granados S; Ruiz León B; Sánchez Morillas L; Fernández Sánchez J; Soriano Gomis V; Borja Segade J; Dalmau Duch G; Guspi Bori R; Miranda Páez A
    J Investig Allergol Clin Immunol; 2016; 26(6):366-373. PubMed ID: 27996943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety aspects of subcutaneous immunotherapy with multiple allergens--a retrospective analysis on polysensitized patients.
    Barth C; Anero F; Pfaar O; Klimek L; Hörmann K; Stuck BA
    Eur Arch Otorhinolaryngol; 2010 Dec; 267(12):1873-9. PubMed ID: 20454971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.